-transparent.png){kind=logo}
A patient with advanced gastric cancer was treated with combined administration of CPT-11 CDDP and 5-FU before operation. CPT-11 was given intravenously at a dose of 30 mg/m2/day on day 1 and day 8. At the same time, 5 mg/m2/day CDDP and 350 mg/m2/day 5-FU were infused for 2 weeks. The patient experienced no other adverse reaction than a mild degree of nausea. Histological examination of the resected specimen revealed complete disappearance of cancer cells both in the stomach and the regional lymphnodes.
Related Publications
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
June 2001,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
September 2006,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
November 1994,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
July 2013,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
August 2010,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
November 2011,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
April 2011,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
February 2009,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
October 2005,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Kume, and
K Okamura, and
D Tanabe, and
T Sakaguchi, and
N Nagamoto, and
S Fukuda
November 2012,
Gan to kagaku ryoho. Cancer & chemotherapy,
